A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease
Titel:
A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease
Auteur:
Alvarez, X. A. Cacabelos, R. Laredo, M. Couceiro, V. Sampedro, C. Varela, M. Corzo, L. Fernandez-Novoa, L. Vargas, M. Aleixandre, M. Linares, C. Granizo, E. Muresanu, D. Moessler, H.